Literature DB >> 18387058

Health-care systems and pharmacoeconomic research in Asia-Pacific region.

Yen-Huei Tarn1, Shanlian Hu, Isao Kamae, Bong-Min Yang, Shu-Chuen Li, Viroj Tangcharoensathien, Yot Teerawattananon, Supon Limwattananon, Aamir Hameed, Syed M Aljunid, Jawahar S Bapna.   

Abstract

Mesh：

Year:  2008        PMID： 18387058     DOI： 10.1111/j.1524-4733.2008.00378.x

Source DB:  PubMed          Journal:  Value Health        ISSN： 1098-3015            Impact factor:   5.725


× No keyword cloud information.
  17 in total

1.  Value-based approaches to healthcare systems and pharmacoeconomics requirements in Asia: South Korea, Taiwan, Thailand and Japan.

Authors:  Isao Kamae
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

Review 2.  Strengthening cost-effectiveness analysis in Thailand through the establishment of the health intervention and technology assessment program.

Authors:  Sripen Tantivess; Yot Teerawattananon; Anne Mills
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

3.  The future of health technology assessment in healthcare decision making in Asia.

Authors:  Bong-Min Yang
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

4.  Cross-national comparison of medical costs shared by payers and patients: a study of postmenopausal women with early-stage breast cancer based on assumption case scenarios and reimbursement fees.

Authors:  Shota Hamada; Shiro Hinotsu; Hiroshi Ishiguro; Masakazu Toi; Koji Kawakami
Journal:  Breast Care (Basel)       Date:  2013-08       Impact factor: 2.860

Review 5.  HCV management in resource-constrained countries.

Authors:  Seng Gee Lim
Journal:  Hepatol Int       Date:  2017-02-21       Impact factor: 6.047

Review 6.  A 2015 roadmap for the management of hepatitis C virus infections in Asia.

Authors:  Seng Gee Lim; Yock Young Dan
Journal:  Korean J Intern Med       Date:  2015-06-29       Impact factor: 2.884

7.  The cost of antiemetic therapy for chemotherapy-induced nausea and vomiting in patients receiving platinum-containing regimens in daily practice in Japan: a retrospective study.

Authors:  Shota Hamada; Shiro Hinotsu; Katsuhito Hori; Hiroshi Furuse; Takehiro Oikawa; Junichi Kawakami; Seiichiro Ozono; Hideyuki Akaza; Koji Kawakami
Journal:  Support Care Cancer       Date:  2011-04-07       Impact factor: 3.603

8.  Uptake of new antidiabetic medications in three emerging markets: a comparison between Brazil, China and Thailand.

Authors:  Christine Y Lu; Isabel Cristina M Emmerick; Peter Stephens; Dennis Ross-Degnan; Anita K Wagner
Journal:  J Pharm Policy Pract       Date:  2015-02-16

9.  The use of comparative effectiveness research to inform policy decisions on the inclusion of bevacizumab for the treatment of macular diseases in Thailand's pharmaceutical benefit package.

Authors:  Thunyarat Anothaisintawee; Pattara Leelahavarong; Tanapat Ratanapakorn; Yot Teerawattananon
Journal:  Clinicoecon Outcomes Res       Date:  2012-12-06

10.  Health economic evaluations of medical devices in the People's Republic of China: A systematic literature review.

Authors:  Rongrong Zhang; Farhang Modaresi; Oleg Borisenko
Journal:  Clinicoecon Outcomes Res       Date:  2015-04-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.